Algert Global’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-12,121
Closed -$3.95M 1607
2024
Q1
$3.95M Sell
12,121
-4,570
-27% -$1.12M 0.15% 223
2023
Q4
$3.18M Sell
16,691
-3,971
-19% -$750K 0.13% 270
2023
Q3
$4.11M Sell
20,662
-808
-4% -$191K 0.19% 164
2023
Q2
$6.13M Sell
21,470
-3,088
-13% -$858K 0.27% 84
2023
Q1
$5.33M Buy
24,558
+4,656
+23% +$907K 0.25% 90
2022
Q4
$4.09M Buy
19,902
+4,461
+29% +$1.13M 0.23% 111
2022
Q3
$4.29M Sell
15,441
-8,435
-35% -$2.15M 0.26% 70
2022
Q2
$4.56M Sell
23,876
-1,364
-5% -$241K 0.34% 27
2022
Q1
$5.23M Buy
25,240
+20,483
+431% +$3.38M 0.34% 31
2021
Q4
$848K Buy
4,757
+170
+4% +$33.5K 0.11% 330
2021
Q3
$944K Buy
+4,587
New +$901K 0.13% 252

Other funds holding SWAV

Algert Global's SWAV Position: Q2 2024 in Review

Algert Global sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 12,121 shares — an estimated $3.95M sold.

Algert Global first reported a position in SWAV in Q3 2021 and held it in 11 quarters. The position peaked at $6.13M in Q2 2023. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Algert Global reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Algert Global sold 12,121 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $3.95M.
  • Algert Global first reported a position in Shockwave Medical, Inc. Common Stock in Q3 2021 and held it in 11 quarters.
  • Algert Global's Shockwave Medical, Inc. Common Stock position peaked at $6.13M in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Algert Global's 13F filing for Q2 2024, filed 15 Aug 2024.